PTGX
#950
Protagonist Therapeutics, Inc. - Common Stock
138.4 9 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.41%
Variación mensual
-6.10%
Variación en los últimos 6 meses
+30.70%
Cambio anual
+84.33%
Cierres anteriores
144.8 8
Open
146.0 0
Mínimo
137.8 8
Máximo
146.0 0
Financials
- Market Capitalization 8.96 B
- Employee 141
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-42.6
Relación precio/flujo de caja
120.66
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 899 |  PCVX Vaxcyte, Inc. - Common Stock | 66.80 USD | -5.45% | +1.43% | +11.89% | +57.92% | 9.94 B USD | ||
| 922 |  KRYS Krystal Biotech, Inc. - Common Stock | 321.16 USD | -3.29% | -1.14% | -5.27% | +71.62% | 9.51 B USD | ||
| 956 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 106.68 USD | -4.82% | +2.01% | -6.83% | +80.51% | 8.87 B USD | ||
| 971 |  CYTK Cytokinetics, Incorporated - Common Stock | 61.62 USD | -1.86% | +0.87% | -14.57% | +6.06% | 8.57 B USD |